Evaluation of safety and efficacy of ZD1839 as monotherapy for Chinese patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Zhang, XT [1 ]
Li, L [1 ]
机构：
[1] CAMS, Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7093
引用
收藏
页码：639S / 639S
页数：1
相关论文
共 50 条
  • [1] Evaluation of efficacy and safety of ZD1839 as monotherapy for Chinese patients with advanced non-small cell lung cancer: Experience from a compassionate-use programme.
    Wang, MZ
    Li, LY
    Wang, SL
    Zhang, XT
    Zhong, W
    Zhang, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 683S - 683S
  • [2] ZD1839 for the treatment of heavily pretreated non-small cell lung cancer.
    Wu, YL
    Yang, X
    Yang, JJ
    Huang, YJ
    Chen, G
    Gu, LJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 701S - 701S
  • [3] ZD1839 (Iressa™) in non-small cell lung cancer
    Herbst, RS
    Kies, MS
    [J]. ONCOLOGIST, 2002, 7 : 9 - 15
  • [4] Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer
    Park, J
    Park, BB
    Kim, JY
    Lee, SH
    Lee, SI
    Kim, HY
    Kim, JH
    Park, SH
    Lee, KE
    Park, JO
    Kim, K
    Jung, CW
    Park, YS
    Im, YH
    Kang, WK
    Lee, MH
    Park, K
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4383 - 4388
  • [5] Evaluation of safety and efficacy of erlotinib as monotherapy for Chinese patients with advanced non-small cell lung cancer
    Zhang, Xiao-Tong
    Li, Long-Yun
    Wang, Meng-Zhao
    Zhang, Li
    Zhong, Wei
    Wang, Shu-Lan
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 184 - 185
  • [6] Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme
    Mu, XL
    Li, LY
    Zhang, XT
    Wang, SL
    Wang, MZ
    [J]. BMC CANCER, 2004, 4 (1)
  • [7] Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme
    Xin-Lin Mu
    Long-Yun Li
    Xiao-Tong Zhang
    Shu-Lan Wang
    Meng-Zhao Wang
    [J]. BMC Cancer, 4
  • [8] Dose-comparative monotherapy trials of ZD1839 in previously treated non-small cell lung cancer patients
    Herbst, RS
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (01) : 30 - 38
  • [9] Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer
    Wang, MZ
    Li, LY
    Wang, SL
    Zhang, XT
    Zhong, W
    Zhang, L
    [J]. CHINESE MEDICAL JOURNAL, 2006, 119 (01) : 63 - 68
  • [10] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Meng-zhao
    [J]. 中华医学杂志(英文版), 2006, (01) : 63 - 68
12345